Skip to main content

Melphalan Injection Shortage

Last Updated: June 6, 2022
Status: Current

Products Affected - Description
    • Alkeran powder for solution for injection, Apo-Pharma, 50 mg, vial, 1 count, NDC 52609-3001-00 - discontinued
    • Melphalan powder for solution for injection, Par Pharmaceuticals, 50 mg, vial, 1 count, NDC 42023-0129-01 - discontinued
Reason for the Shortage
    • Apo-Pharma discontinued Alkeran injection.
    • Athenex has melpalan available.
    • Dr. Reddy's has melphalan injection available.
    • Fresenius Kabi has melphalan injection available.
    • Meitheal has melphalan injection available.
    • Mylan Institutional did not provide a reason for the shortage.
    • Teva has melphalan injection available.
    • Acrotech has Evomela injection available.
Available Products
    • Evomela powder for solution for injection, Acrotech, 50 mg, vial, 1 count, NDC 72893-0001-01
    • Melphalan powder for solution for injection, Athenex, 50 mg, vial, 1 count, NDC 70860-0214-61
    • Melphalan powder for solution for injection, Dr. Reddy's, 50 mg, vial, 1 count, NDC 43598-0392-48
    • Melphalan powder for solution for injection, Fresenius Kabi, 50 mg, vial, 1 count, NDC 63323-0760-20
    • Melphalan powder for solution for injection, Meitheal Pharmaceuticals, 50 mg, vial, 1 count, NDC 71288-0112-90
    • Melphalan powder for solution for injection, Mylan Institutional, 50 mg, vial, 1 count, NDC 67457-0195-01
    • Melphalan powder for solution for injection, Teva, 50 mg, vial, 1 count, NDC 45963-0686-02

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated June 6, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 28, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.